These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 2824676

  • 1. Cell-mediated immunity to varicella-zoster virus infection in strain 2 guinea pigs.
    Jenski L, Myers MG.
    J Med Virol; 1987 Sep; 23(1):23-30. PubMed ID: 2824676
    [Abstract] [Full Text] [Related]

  • 2. Immunity in strain 2 guinea-pigs inoculated with vaccinia virus recombinants expressing varicella-zoster virus glycoproteins I, IV, V or the protein product of the immediate early gene 62.
    Lowry PW, Solem S, Watson BN, Koropchak CM, Thackray HM, Kinchington PR, Ruyechan WT, Ling P, Hay J, Arvin AM.
    J Gen Virol; 1992 Apr; 73 ( Pt 4)():811-9. PubMed ID: 1321876
    [Abstract] [Full Text] [Related]

  • 3. VZV T cell-mediated immunity.
    Weinberg A, Levin MJ.
    Curr Top Microbiol Immunol; 2010 Apr; 342():341-57. PubMed ID: 20473790
    [Abstract] [Full Text] [Related]

  • 4. Cell-mediated immunity to varicella zoster virus in children being treated for cancer.
    Hayes FA, Feldman S.
    Cancer; 1978 Jul; 42(1):159-63. PubMed ID: 208747
    [Abstract] [Full Text] [Related]

  • 5. Experimental infection and immune response of guinea pigs with varicella-zoster virus.
    Matsunaga Y, Yamanishi K, Takahashi M.
    Infect Immun; 1982 Aug; 37(2):407-12. PubMed ID: 6288560
    [Abstract] [Full Text] [Related]

  • 6. Detection of varicella-zoster virus-specific IgA antibodies in varicella and zoster patients and in healthy adults of various ages by solid-phase radioimmunoassay.
    Levy E, Mosovitz B, Friedman M, Sarov I.
    Intervirology; 1983 Aug; 20(2-3):123-8. PubMed ID: 6313543
    [Abstract] [Full Text] [Related]

  • 7. Immunogenicity of a recombinant varicella-zoster virus gE-IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivation.
    Jacquet A, Haumont M, Massaer M, Garcia L, Mazzu P, Daminet V, Grégoire D, Jacobs P, Bollen A.
    Vaccine; 2002 Feb 22; 20(11-12):1593-602. PubMed ID: 11858867
    [Abstract] [Full Text] [Related]

  • 8. Delayed hypersensitivity skin test to detect susceptibility to varicella and zoster.
    Berger R, Luescher D, Just M, D'Hondt E, Bogaert H.
    Postgrad Med J; 1985 Feb 22; 61 Suppl 4():137-41. PubMed ID: 3014471
    [Abstract] [Full Text] [Related]

  • 9. Varicella-zoster virus infection of strain 2 guinea pigs.
    Myers MG, Stanberry LR, Edmond BJ.
    J Infect Dis; 1985 Jan 22; 151(1):106-13. PubMed ID: 2981274
    [Abstract] [Full Text] [Related]

  • 10. Cell-mediated immunity to varicella-zoster virus.
    Arvin AM.
    J Infect Dis; 1992 Aug 22; 166 Suppl 1():S35-41. PubMed ID: 1320649
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cellular and humoral immune responses to varicella-zoster virus in immunocompromised patients during and after varicella-zoster infections.
    Gershon AA, Steinberg SP.
    Infect Immun; 1979 Jul 22; 25(1):170-4. PubMed ID: 225270
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cellular and humoral immunity to varicella zoster virus glycoproteins in immune and susceptible human subjects.
    Giller RH, Winistorfer S, Grose C.
    J Infect Dis; 1989 Dec 22; 160(6):919-28. PubMed ID: 2555419
    [Abstract] [Full Text] [Related]

  • 17. Ability of yeast Ty-VLPs (virus-like particles) containing varicella-zoster virus (VZV)gE and assembly protein fragments to induce in vitro proliferation of human lymphocytes from VZV immune patients.
    Welsh MD, Harper DR, Garcia-Valcarcel M, Fowler WJ, Aitken C, Jeffries DJ, Layton GT.
    J Med Virol; 1999 Sep 22; 59(1):78-83. PubMed ID: 10440812
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Perspectives on vaccines against varicella-zoster virus infections.
    Gershon AA, Gershon MD.
    Curr Top Microbiol Immunol; 2010 Sep 22; 342():359-72. PubMed ID: 20232192
    [Abstract] [Full Text] [Related]

  • 20. Humoral and cellular immunity to varicella-zoster virus: an overview.
    Arvin AM.
    J Infect Dis; 2008 Mar 01; 197 Suppl 2():S58-60. PubMed ID: 18419410
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.